LIPID PEROKSIDLANISHINING KIMYOVIY MEXANIZMLARI VA YURAK-QON TOMIR KASALLIKLARIDAGI AHAMIYATI
Shaismatova G. X., Xodjimurodov D. I., Pardayev S. M. & Ikromova S. R.
Annotatsiya
Mazkur maqolada lipid peroksidlanishining kimyoviy mexanizmlari, hujayra membranalariga va biomolekulalarga ta’siri, shuningdek, yurak-qon tomir kasalliklaridagi roli o‘rganildi. maqolada lipid peroksidlanish jarayonini oldini olish va davolash bo‘yicha yondashuvlar ham tahlil qilindi.
Adabiyotlar
- Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
- Madam A., Smith J., et al. Oxidized LDL and atherosclerosis: Molecular mechanisms. Cardiovasc Res. 2015;107:242–254.
- Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 4th Edition. Oxford University Press, 2006.
- Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2017;4:180–183.
- 5.Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2002;43:213–228.
- Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4:118–126.
- Madam A., et al. Lipid peroxidation in cardiovascular diseases: Clinical implications. Clin Chim Acta. 2016;456:52–60.
- Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655–673.
- Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707–727.
- Madam B., et al. Antioxidant therapy in cardiovascular disease: Current evidence. Curr Opin Lipidol. 2013;24:356–362.